The investment bank maintained its stock ratings for Hologic, Cepheid, and T2 Biosystems.
The self-contained, cartridge-based test runs on the firm's GeneXpert system.
The company is using a $3 million, three-year grant to clinically validate the test, which it hopes will be the first of its kind approved by the FDA.
Sensitivity of GeneXpert MTB/RIF was better than microscopy, but low enough compared to culture to conclude that a negative Xpert result does not rule out TB in children.
The partners will jointly evaluate Globavir's PanGlob RT-PCR-based Dengue diagnostic assay.
In Science this week: self-assembly of DNA components in solution, and more.
Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.
A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.
With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.